Mikael Eriksson

Mikael Eriksson's AcademicInfluence.com Rankings

Mikael Eriksson

Biology

#9784

World Rank

#13031

Historical Rank

Cell Biology

#433

World Rank

#444

Historical Rank

Genetics

#1008

World Rank

#1106

Historical Rank

Molecular Biology

#1364

World Rank

#1391

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Mikael Eriksson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mikael Eriksson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effects of torcetrapib in patients at high risk for coronary events. (2007) (2393)
Association analysis identifies 65 new breast cancer risk loci (2017) (922)
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. (2012) (887)
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014) (642)
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (624)
Effects of torcetrapib in patients at high risk for coronary events (2008) (624)
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. (2008) (592)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
MicroRNA Related Polymorphisms and Breast Cancer Risk (2014) (557)
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer (2015) (502)
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. (2008) (482)
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants (2015) (471)
Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: a case-control study. (1981) (432)
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015) (425)
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. (2020) (322)
Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials. (2014) (321)
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial (2016) (314)
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial (2015) (274)
Soft-tissue sarcomas and exposure to chemical substances: a case-referent study. (1981) (273)
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort (2019) (272)
Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2012) (254)
Nordic MCL2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem‐cell support: still very long survival but late relapses do occur (2012) (247)
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (244)
A case–control study of non‐Hodgkin lymphoma and exposure to pesticides (1999) (243)
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. (1999) (236)
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment† (2014) (235)
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (230)
Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case‐control study (1998) (219)
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (216)
Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. (2003) (212)
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2021) (206)
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver (2004) (199)
Identification of Novel Genetic Markers of Breast Cancer Survival (2015) (185)
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). (2010) (174)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) (174)
Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial. (2016) (167)
Exposure to Pesticides as Risk Factor for Non-Hodgkin's Lymphoma and Hairy Cell Leukemia: Pooled Analysis of Two Swedish Case-control Studies (2002) (166)
Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans (2010) (162)
15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau (2016) (155)
Pesticide exposure as risk factor for non‐Hodgkin lymphoma including histopathological subgroup analysis (2008) (152)
Influence of age on the metabolism of plasma low density lipoproteins in healthy males. (1991) (151)
In utero exposure to persistent organic pollutants in relation to testicular cancer risk. (2006) (150)
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. (2013) (150)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (147)
Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. (1990) (142)
Exposure to phenoxyacetic acids, chlorophenols, or organic solvents in relation to histopathology, stage, and anatomical localization of non-Hodgkin's lymphoma. (1994) (133)
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (131)
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial (2017) (129)
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. (2004) (125)
Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma. (2009) (119)
Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia. (1995) (116)
Occupational and other environmental factors and multiple myeloma: a population based case-control study. (1992) (115)
The association between soft tissue sarcomas and exposure to phenoxyacetic acids. A new case‐referent study (1988) (113)
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2014) (112)
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. (2015) (107)
Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe (2010) (107)
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. (2013) (106)
Soft Tissue and Visceral Sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii102, 2014) (2015) (104)
Risk factors and tumor characteristics of interval cancers by mammographic density. (2015) (101)
Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma. (1989) (97)
Hepatic cholesterol metabolism in estrogen-treated men. (1992) (94)
Case-Control Study on Concentrations of Organohalogen Compounds and Titers of Antibodies to Epstein-Barr Virus Antigens in the Etiology of Non-Hodgkin Lymphoma (2001) (92)
A Minimum Data Set for Sharing Biobank Samples, Information, and Data: MIABIS. (2012) (92)
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up. (2020) (87)
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. (2015) (86)
Corrections to "Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up". (2018) (86)
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2021) (85)
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant (2003) (84)
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. (2021) (83)
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing (2016) (83)
Twelve versus 36 months of adjuvant imatinib (IM) as treatment of operable GIST with a high risk of recurrence: Final results of a randomized trial (SSGXVIII/AIO). (2011) (81)
Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity. (2017) (81)
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
Patients with atherosclerosis may have increased circulating levels of 27‐hydroxycholesterol and cholestenoic acid (2005) (78)
Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA) (2017) (78)
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group (2015) (77)
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma (2018) (75)
Concentrations of polychlorinated biphenyls in blood and the risk for testicular cancer. (2004) (75)
Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case–control study in Europe (2010) (74)
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial. (2010) (74)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia. (1991) (73)
Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer. (2015) (72)
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (71)
Is the decline of the increasing incidence of non-Hodgkin lymphoma in Sweden and other countries a result of cancer preventive measures? (2003) (70)
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population (2021) (70)
Adjuvant therapy in primary GIST: state-of-the-art. (2012) (69)
A clinical model for identifying the short-term risk of breast cancer (2017) (67)
Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males. (1996) (66)
Automated Measurement of Volumetric Mammographic Density: A Tool for Widespread Breast Cancer Risk Assessment (2014) (65)
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation (2016) (63)
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium (2014) (62)
Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. (1995) (62)
Use of cellular or cordless telephones and the risk for non-Hodgkin’s lymphoma (2005) (62)
Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome. (1997) (61)
Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study (2004) (61)
Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection (2016) (61)
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib (2014) (59)
Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment (2004) (58)
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. (2012) (58)
Use of cellular and cordless telephones and risk of testicular cancer. (2007) (57)
Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy (1993) (56)
Gastrointestinal Stromal Tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii21, 2014) (2015) (54)
Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study. (1993) (54)
Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-center case–control study (2004) (53)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities (2021) (53)
Differences in mammographic density between Asian and Caucasian populations: a comparative analysis (2016) (53)
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. (2015) (51)
HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver. (2010) (50)
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 (2015) (50)
Growth Hormone Induces Low-Density Lipoprotein Clearance but not Bile Acid Synthesis in Humans (2004) (49)
Histology-driven chemotherapy of soft-tissue sarcoma. (2010) (49)
The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case–control study (2002) (48)
Occupational exposures and risk of gastric cancer in a population-based case-control study. (1999) (48)
Intravascular haemolysis and increased prevalence of myeloma and monoclonal gammopathy in congenital dyserythropoietic anaemia, type III (1994) (47)
Corrections to "Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up". (2018) (47)
Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence? (2016) (46)
Platelet Activity In Vivo in Hyperlipoproteinemia – Importance of Combined Hyperlipidemia (1998) (46)
Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels (1990) (46)
Evaluation of an Internet-Based Hearing Test—Comparison with Established Methods for Detection of Hearing Loss (2008) (45)
LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial (2016) (45)
MED-PED: An Integrated Genetic Strategy for Preventing Early Deaths (1996) (45)
Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register (2011) (45)
Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism? (1997) (45)
The organization of the pontine projection to lateral cerebellar areas in the rat: dual zones in the pons (1978) (45)
Occupational risks for uveal melanoma results from a case-control study in nine European countries (2005) (45)
Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver‐selective thyroid hormone receptor agonist eprotirome (2015) (44)
Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL. (2002) (44)
Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma. (2009) (44)
Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (44)
Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C‐III (2017) (44)
Oestrogen‐induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol‐fed rabbit (1989) (44)
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (43)
Post‐relapse survival in patients with Ewing sarcoma (2015) (42)
Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels (2016) (42)
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (42)
High‐dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: Final results of the ISG/SSG II study (2014) (41)
Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis. (2016) (41)
Oral infections and dental factors in relation to oral cancer: a Swedish case–control study (1998) (41)
Low-dose atorvastatin in severe chronic kidney disease patients: A randomized, controlled endpoint study (2005) (40)
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. (2014) (40)
Metabolism of lipoprotein remnants in humans. Studies during intestinal infusion of fat and cholesterol in subjects with varying expression of the low density lipoprotein receptor. (1991) (40)
Effects of selective LDL‐apheresis and pravastatin therapy on platelet function in familial hypercholesterolaemia (1994) (39)
Testicular cancer and occupational exposure to polyvinyl chloride plastics: A case‐control study (2004) (39)
Occupational exposures as risk factors for oral cancer evaluated in a Swedish case-control study. (1999) (39)
Body mass index and breast cancer survival: a Mendelian randomization analysis (2017) (38)
European multi-centre case-control study on risk factors for rare cancers of unknown aetiology. (2005) (37)
Common diseases as determinants of menopausal age. (2016) (37)
A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study. (2003) (37)
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. (1997) (36)
Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: A prospective study. (2015) (35)
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2020) (35)
Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors (2015) (35)
The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma (2017) (35)
MAP plus maintenance pegylated interferon α-2b (MAPIfn) versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 "good response" randomization. (2013) (34)
A comprehensive tool for measuring mammographic density changes over time (2018) (34)
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts (2021) (34)
Occupational factors and risk of adult bone sarcomas: A multicentric case‐control study in Europe (2006) (33)
Response to Imatinib Rechallenge of GIST That Recurs Following Completion of Adjuvant Imatinib Treatment - the First Analysis in the SSGXVIII/AIO Trial Patient Population (2011) (33)
Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients. (2009) (33)
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016) (33)
Effects of high‐dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism (2011) (33)
Control of ACAT2 liver expression by HNF1 Published, JLR Papers in Press, June 16, 2005. DOI 10.1194/jlr.M400450-JLR200 (2005) (33)
Simultaneous determination of pyrimethamine and sulphadoxine in human plasma by high-performance liquid chromatography. (1985) (32)
Occupation and small bowel adenocarcinoma: a European case-control study (2000) (32)
No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia. (1997) (32)
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort (2018) (31)
Common germline polymorphisms associated with breast cancer-specific survival (2015) (31)
PCNA, Ki-67, p53, bcl-2 and Prognosis in Intraoral Squamous Cell Carcinoma of the Head and Neck (1997) (31)
Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era? (1999) (30)
Gemfibrozil treatment of combined hyperlipoproteinemia. No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels. (1996) (30)
Quality of life in patients with familial hypercholesterolaemia (2002) (30)
Methanol production from lignin‐related substances by Phanerochaete chrysosporium (1985) (30)
Medical risk factors for small-bowel adenocarcinoma with focus on Crohn disease: a European population-based case-control study. (2001) (29)
Area and Volumetric Density Estimation in Processed Full-Field Digital Mammograms for Risk Assessment of Breast Cancer (2014) (29)
Metaanalysis of 4 Swedish case-control studies on exposure to pesticides as risk-factor for soft-tissue sarcoma including the relation to tumor-localization and histopathological type. (1995) (29)
Sarcomas with spindle cell morphology. (2009) (29)
Intensified CHOP with Rituximab for Intermediate or High-Risk Non-Hodgkin’s Lymphoma: Interim Analysis of a Randomized Phase III Trial in Elderly Patients by the Dutch HOVON and Nordic Lymphoma Groups. (2005) (29)
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk (2019) (29)
Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial (2011) (29)
L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. (1998) (28)
Developing a semantically rich ontology for the biobank-administration domain (2013) (28)
Depressive Symptoms in Hypothyroid Disorder with some Observations on Biochemical Correlates (2001) (28)
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2 (2008) (28)
Observations on two members of the Swedish family with congenital dyserythropoietic anaemia, type III (1993) (28)
Occupational Risk Factors for Small Bowel Carcinoid Tumor: A European Population-Based Case-Control Study (2002) (28)
Angioid streaks are part of a familial syndrome of dyserythropoietic anaemia (CDA III) (1997) (28)
Case-control study on the use of mobile and cordless phones and the risk for malignant melanoma in the head and neck region. (2011) (28)
The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans (1997) (28)
Familial malignant blood disease in the county of Jämtland, Sweden (1987) (27)
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes (2022) (27)
Naturally occurring alterations of cortical layers surrounding the fissura prima of rat cerebellum (1980) (27)
Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers. (2015) (27)
Control of ACAT2 Liver Expression by HNF4&agr;: Lesson From MODY1 Patients (2009) (27)
Genetic characterization of Swedish patients with familial hypercholesterolemia: a heterogeneous pattern of mutations in the LDL receptor gene. (2002) (26)
LDL–apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion (2000) (26)
18F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study (2015) (26)
Volumetric mammographic density: heritability and association with breast cancer susceptibility loci. (2014) (25)
Twelve versus 36 months of adjuvant imatinib (IM) as treatment of operable GIST with a high risk of recurrence: Final results of a randomized trial (SSGXVIII/AIO). (2011) (25)
Gemfibrozil enhances platelet activity in patients with combined hyperlipoproteinemia. (1995) (25)
Long-term efficacy of pitavastatin versus simvastatin (2011) (25)
Hepatic ACAT2 Knock Down Increases ABCA1 and Modifies HDL Metabolism in Mice (2014) (25)
A non-random deletion in the p53 gene in oral squamous cell carcinoma. (1996) (25)
An Internet-Based Hearing Test for Simple Audiometry in Nonclinical Settings: Preliminary Validation and Proof of Principle (2010) (25)
Improved treatment of glioblastoma – changes in survival over two decades at a single regional Centre (2019) (24)
Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX). (2018) (24)
Background risk of breast cancer and the association between physical activity and mammographic density (2015) (24)
Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells. (2007) (24)
Hydrogen concentration in expired air analyzed with a new hydrogen sensor, plasma glucose rise, and symptoms of lactose intolerance after oral administration of 100 gram lactose. (1985) (24)
ACAT2 and human hepatic cholesterol metabolism: identification of important gender-related differences in normolipidemic, non-obese Chinese patients. (2009) (24)
Statins inhibit expression of thioredoxin reductase 1 in rat and human liver and reduce tumour development. (2012) (23)
Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall. (2011) (23)
Hormonal exposures and the risk of uveal melanoma (2010) (23)
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. (2013) (23)
Identification of two novel mammographic density loci at 6Q25.1 (2015) (23)
Cholesteryl esters and ACAT (2012) (23)
Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data (2019) (22)
Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening. (2020) (22)
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium (2014) (22)
Low‐density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome (1997) (22)
Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: A cross‐sectional study (2016) (22)
Determinants of Mammographic Density Change (2019) (22)
Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects. (1996) (21)
Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma (2014) (21)
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. (2012) (21)
CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer (2019) (21)
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid‐lowering in primary care (1998) (21)
Incidence of neoplasms in ages 0-19 y in parts of Sweden with high 137Cs fallout after the Chernobyl accident. (1996) (21)
Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer. (2018) (20)
[Case- control study of malignant mesenchymal soft tissue tumors and exposure to chemical substances]. (1979) (20)
Gastrointestinal stromal tumor: a method for optimizing the timing of CT scans in the follow-up of cancer patients. (2014) (20)
The Association of Lipoprotein(a) Plasma Levels With Prevalence of Cardiovascular Disease and Metabolic Control Status in Patients With Type 1 Diabetes (2019) (20)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
MAPIE vs MAP as postoperative chemotherapy in patients with a poor response to preoperative chemotherapy for newly-diagnosed osteosarcoma: results from EURAMOS-1 (Paper 032) (2014) (20)
Adjuvant therapy in primary GIST: state-of-the-art. (2012) (20)
Phase III Trial of 2-Weekly CHOP with Rituximab for Aggressive B-Cell Non-Hodgkin’s Lymphoma in Elderly Patients. (2006) (19)
Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients (2015) (19)
Morphological differentiation of tau–green fluorescent protein embryonic stem cells into neurons after co-culture with auditory brain stem slices (2009) (19)
Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes. (1999) (19)
Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries. (2021) (19)
Malignant lymphoproliferative diseases in occupations with potential exposure to phenoxyacetic acids or dioxins: a register-based study. (1992) (18)
Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer (2018) (18)
The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity (2018) (18)
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
Mammographic microcalcifications and risk of breast cancer (2021) (18)
Survival, migration, and differentiation of Sox1-GFP embryonic stem cells in coculture with an auditory brainstem slice preparation. (2008) (17)
ASBESTOS EXPOSURE AND MALIGNANT LYMPHOMA (1982) (17)
Interval breast cancer is associated with other types of tumors (2019) (17)
Combined treatment with cholestyramine and nicotinic acid in heterozygous familial hypercholesterolaemia: effects on biliary lipid composition (1986) (17)
Increased cancer incidence in physicians, dentists, and health care workers. (1998) (17)
Statin-induced myopathy in a usual care setting—a prospective observational study of gender differences (2016) (16)
Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment (2018) (16)
Mammographic Density Change and Risk of Breast Cancer. (2019) (16)
Evidence for a lack of regulatory importance of the 12 alpha-hydroxylase in formation of bile acids in man: an in vivo study. (1983) (16)
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
Occupational exposure to organic solvents and risk of male breast cancer: a European multicenter case-control study. (2018) (16)
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
Dioxin and mortality from cancer. (1991) (15)
Atorvastatin Treatment Induces Uptake and Efflux Transporters in Human Liver (2013) (15)
HNF1α and SREBP2 are important regulators of NPC1L1 in human liver (2010) (15)
Serum thymidine kinase in congenital dyserythropoietic anaemia type III (1994) (15)
Differential effects of oligosaccharides on the hydration of simple cations. (2008) (15)
Body size in early life and risk of breast cancer (2017) (15)
Bezafibrate therapy and biliary lipids: effects of short‐term and long‐term treatment in patients with various forms of hyperlipoproteinaemia (1987) (15)
Expression of p53, PCNA, Ki-67 and bcl-2 in relation to risk factors in oral cancer - a molecular epidemiological study. (2003) (14)
Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer (2018) (14)
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. (2015) (14)
Pesticide exposure in farming and forestry and the risk of uveal melanoma (2011) (14)
Referral patterns, treatment and outcome of high‐grade malignant bone sarcoma in Scandinavia—SSG Central Register 25 years' experience (2015) (14)
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. (2014) (14)
Working to improve the management of sarcoma patients across Europe: a policy checklist (2018) (13)
Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors (2020) (13)
Hormonal determinants of mammographic density and density change (2020) (13)
HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo (2015) (13)
Detection of potential microcalcification clusters using multivendor for‐presentation digital mammograms for short‐term breast cancer risk estimation (2019) (12)
[Malignant lymphoma and exposure to chemical substances, in particular organic solvents, chlorphenol and phenoxyacetates]. (1980) (12)
Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers. (2015) (12)
Tobacco smoking and alcohol consumption as risk factors for thymoma - A European case-control study. (2019) (12)
Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism. (2016) (12)
Non‐steady‐state kinetics of low density lipoproteins in man: studies after plasma exchange in healthy subjects and patients with familial hypercholesterolaemia (1993) (12)
TG-interacting factor 1 acts as a transcriptional repressor of sterol O-acyltransferase 2[S] (2014) (12)
Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years (2020) (12)
Occupational exposure to electromagnetic fields and sex-differential risk of uveal melanoma (2010) (12)
Agent Orange in War Medicine: An Aftermath Myth (1998) (12)
SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour (2017) (12)
High serum vascular endothelial growth factor level is an adverse prognostic factor for high‐risk diffuse large B‐cell lymphoma patients treated with dose‐dense chemoimmunotherapy (2012) (12)
Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer (2018) (12)
Analysis of ubiquinone and tocopherol levels in normal and hyperlipidemic human plasma (1998) (11)
Inherited factors contribute to an inverse association between preeclampsia and breast cancer (2018) (11)
SOFT-TISSUE SARCOMAS, PHENOXY HERBICIDES, AND CHLORINATED PHENOLS (1981) (11)
Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial (2021) (11)
Risk for fatal statin‐induced rhabdomyolysis as a consequence of misinterpretation of ‘evidence‐based medicine’ (2005) (11)
Low frequency of the common Norwegian and Finnish LDL‐receptor mutations in Swedish patients with familial hypercholesterolaemia (1998) (11)
Effect of Statin Treatment on Plasma 4β-Hydroxycholesterol Concentrations. (2016) (11)
Adipose tissue concentrations of dioxins and dibenzofurans in patients with malignant lymphoproliferative diseases and in patients without a malignant disease. (1995) (11)
Time-resolved fluorometry in the genetic diagnosis of familial defective apolipoprotein B-100. (1994) (11)
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2015) (10)
Prospective Evaluation of a Breast Cancer Risk Model Integrating Classical Risk Factors and Polygenic Risk in 15 Cohorts from Six Countries (2019) (10)
Occupational exposure to endocrine-disrupting chemicals and the risk of uveal melanoma. (2012) (10)
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study. (2021) (10)
Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses (2020) (10)
Gemfibrozil-induced decrease in serum ubiquinone and alpha- and gamma-tocopherol levels in men with combined hyperlipidaemia. (1998) (10)
Mantle Cell Lymphoma Can Be Cured by Intensive Immunochemotherapy with In-Vivo Purged Stem-Cell Support; Final Report of the Nordic Lymphoma Group MCL2 Study. (2007) (9)
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
MS389 PITAVASTATIN 4 mg SHOWS COMPARABLE LDL-CHOLESTEROL AND SUPERIOR TRIGLYCERIDE REDUCTION TO SIMVASTATIN 40 mg IN HIGH-RISK PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIA (2010) (9)
Genetic testing for familial hypercholesterolemia among survivors of acute coronary syndrome (2018) (9)
Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden (2021) (9)
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1 (2017) (9)
Comparison of self-reported and register-based hospital medical data on comorbidities in women (2019) (9)
The impact of alcohol consumption and physical activity on breast cancer: The role of breast cancer risk (2019) (9)
Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study (2019) (9)
Event-free survival and overall survival in 2,253 patients with osteosarcoma registered to EURAMOS-1 (2015) (9)
Cholecystokinin peptides in cerebrospinal fluid: a study in healthy male subjects (1997) (8)
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study (2021) (8)
Associations between childhood body size and seventeen adverse outcomes: analysis of 65,057 European women (2017) (8)
Glutathione S-transferase genotype and p53 mutations in adenocarcinoma of the small intestine. (2003) (8)
Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening (2018) (8)
Biliary lipids in familial combined hyperlipidaemia: effects of acipimox therapy (1990) (8)
Lipid lowering in severe familial hypercholesterolaemia: efficacy and safety of a new regenerating system for selective apheresis of apolipoprotein B‐containing lipoproteins (1989) (8)
The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI (2020) (7)
Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density (2018) (7)
The association of single nucleotide polymorphisms (SNPs) with breast density and breast cancer survival: the Malmö Diet and Cancer Study (2020) (7)
A European treatment protocol for bone sarcoma in patients older than 40 years. (2009) (7)
Metabolism of plasma low density lipoproteins in familial combined hyperlipidaemia: effect of acipimox therapy (1992) (7)
Cholesterol lowering and cerebrospinal fluid neurotransmitters: Increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin administration to healthy male volunteers (1996) (7)
Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice. (2019) (7)
Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic (2014) (7)
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial (2022) (7)
Combining Rome III criteria with alarm symptoms provides high specificity but low sensitivity for functional gastrointestinal disorders in children (2018) (7)
Three vs. 1 year of adjuvant imatinib (IM) for operable high-risk GIST: The second planned analysis of the randomized SSGXVIII/AIO trial. (2015) (7)
Weight gain and blood pressure. (2019) (7)
Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population‐based cohort studies and two‐sample Mendelian randomization analyses (2020) (7)
Plasma lipoprotein(a) measured in the routine clinical care is associated to atherosclerotic cardiovascular disease during a 14-year follow-up. (2021) (6)
SHORT-TERM AND LONG-TERM EFFECTS OF PITAVASTATIN AND SIMVASTATIN ON FASTING PLASMA GLUCOSE IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA AND ≥2 RISK FACTORS FOR CORONARY HEART DISEASE (2012) (6)
Changes in biliary lipid output after interruption of pravastatin treatment in humans (1996) (6)
Plasma exchange in a patient with heterozygous familial hypercholesterolaemia resistant to drug therapy. (2009) (6)
Micro‐ and Macrocirculatory Effects of Apheresis in Patients withFamilial Hyperlipidemia (2003) (6)
Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study (2022) (6)
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2018) (6)
The Genetic Basis of Quality of Life in Healthy Swedish Women: A Candidate Gene Approach (2015) (6)
Mammographic features are associated with cardiometabolic disease risk and mortality (2021) (6)
Longitudinal fluctuation in mammographic percent density differentiates between interval and screen‐detected breast cancer (2017) (6)
SOFT-TISSUE SARCOMA AND EXPOSURE TO DIOXINS (1986) (6)
A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care (2022) (6)
Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2021) (6)
The association between cancer mortality and dioxin exposure: a comment on the hazard of repetition of epidemiological misinterpretation. (1991) (6)
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 cohort (2018) (6)
Remission by chemotherapy of the Eaton-Lambert myasthenic syndrome in a patient with small cell bronchogenic carcinoma. (2009) (6)
ALT-GIST: Randomized phase II trial of imatinib alternating with regorafenib versus imatinib alone for the first-line treatment of metastatic gastrointestinal stromal tumor (GIST). (2019) (6)
Distinct reproductive risk profiles for intrinsic-like breast cancer subtypes: pooled analysis of population-based studies. (2022) (5)
Changes in cerebrospinal fluid signalling substances and appetite scores following 48 h fast in healthy volunteers (2003) (5)
Unique case of cerebrotendinous xanthomatosis revisited: All the mutations responsible for this disease are present in the CYP27A1 gene (2018) (5)
Three versus one year of adjuvant imatinib for high-risk gastrointestinal stromal tumor (GIST): Survival analysis of a randomized trial after 10 years of follow-up. (2020) (5)
In vivo measurement of the effective atomic number of breast skin using spectral mammography (2018) (5)
Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study (2016) (5)
Role of TG-interacting factor (Tgif) in lipid metabolism. (2015) (5)
Diiodothyronines regulate metabolic homeostasis in primary human hepatocytes by modulating mTORC1 and mTORC2 activity (2020) (5)
Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST) (2021) (5)
Increased cancer incidence in physicians, dentists and health care workers (1993) (5)
Effect of atorvastatin and simvastatin in obtaining targets for lipids in secondary prevention. The treat-to-target study (3T) (2000) (5)
Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia (2008) (5)
Predictors of mammographic microcalcifications (2020) (5)
Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women (2021) (5)
LEADER-6: Baseline renal function and associated factors in a high cardiovascular risk type 2 diabetes population. (2016) (4)
Incorporating progesterone receptor expression into the PREDICT breast prognostic model. (2022) (4)
Distinct metabolic hallmarks of WHO classified adult glioma subtypes (2022) (4)
Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer (2020) (4)
Physical activity and mammographic density in an Asian multi-ethnic cohort (2018) (4)
CSF taurine level is influenced by plasma cholesterol and the CYP2D6 phenotype (2002) (4)
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments. (2022) (4)
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID‐19 Pandemic (2020) (4)
EURAMOS-1 study : Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma (2012) (4)
Overexpression of transforming growth factor β induced factor homeobox 1 represses NPC1L1 and lowers markers of intestinal cholesterol absorption. (2018) (4)
Epidemiological studies on cancer and exposure to dioxins and related compounds (2012) (4)
L-thyroxine treatment in primary hypothyroidism does not increase the content of free triiodothyronine in cerebrospinal fluid: A pilot study (2011) (4)
Lomitapide treatment in a female with homozygous familial hypercholesterolaemia: a case report (2020) (4)
Carotid atherosclerosis progression and ACAT inhibition. (2009) (3)
Mendelian randomisation study of smoking exposure in relation to breast cancer risk (2021) (3)
Mammography features for early markers of aggressive breast cancer subtypes and tumor characteristics: A population‐based cohort study (2020) (3)
Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study (2020) (3)
High‐density lipoprotein‐associated sphingosine‐1‐phosphate activity in heterozygous familial hypercholesterolaemia (2017) (3)
Non-Hodgkin lymphoma and previous exposure to hexachlorophene: a case report. (1992) (3)
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) (3)
Cholecystokinin peptides in cerebrospinal fluid: a pilot study in hypothyroid patients (1999) (3)
How to handle hypertriglyceridaemia in acute pancreatitis – Still a vote for conservatives? (2019) (3)
Trust in Public Safety Answering Points: A Swedish National Survey in the Late Modern Network Society (2011) (3)
Soat2 ties cholesterol metabolism to β‐oxidation and glucose tolerance in male mice (2022) (3)
[New experiences strengthen the connection between dioxins, phenoxy acids and malignant tumors]. (1991) (3)
Sense of coherence and risk of breast cancer (2020) (2)
Nordic MCL2 Trial of 1St-Line Intensive Immunochemotherapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: Still Encouraging Results After Median 5½ Years Observation Time (2011) (2)
Cholecystokinin peptides in cerebrospinal fluid: a study in healthy male subjects lumbar-punctured without preceding strict bed-rest (1999) (2)
[Increased risk of soft tissue sarcoma in persons exposed to dioxin]. (1991) (2)
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (2)
On the Misinterpretation of Epidemiological Evidence (1994) (2)
PM385 Safety, Tolerability, And Efficacy Of Long-Term Administration Of Monthly AMG 145 In Subjects With Heterozygous Familial Hypercholesterolemia (2014) (2)
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study (2022) (2)
Malformation of purkinje cell dendrites induced by graft-versus-host disease (1980) (2)
CSF taurine level is influenced by plasma cholesterol and the CYP2D6 phenotype (2002) (2)
Founder effects facilitate the use of a genotyping‐based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia (2021) (2)
Abstract P4-06-13: BRCA1/2 mutations identified by screening a large unselected breast cancer cohort in Sweden (2018) (2)
Generation of new hepatocyte-like in vitro models better resembling human lipid metabolism. (2020) (2)
Two truncating variants in FANCC and breast cancer risk (2019) (2)
Risk Assessment in Population-Based Breast Cancer Screening. (2022) (2)
In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women—A GWAS Study Using the iCOGS Custom Genotyping Array (2015) (1)
Developing a semantically rich ontology for the biobank-administration domain (2013) (1)
Rare cancers of unknown etiology: lessons learned from a European multi-center case–control study (2020) (1)
Kinetic analysis of LDL apoB transport and metabolism in non-steady states (2000) (1)
Control of ACAT2 liver expression by HNF1 (2005) (1)
Predictors for discontinuation of adjuvant hormone therapy in breast cancer patients (2016) (1)
Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (1)
Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns (2020) (1)
Nordic Mantle Cell Lymphoma (MCL) Project: Preemptive Rituximab Treatment of Molecular Relapse Following Autotransplant Can Reinduce Molecular Remission and Prolonged Disease-Free Survival. (2005) (1)
Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort (2022) (1)
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2015) (1)
Adipose-tissue concentrations of dioxins and dibenzofurans in potentially exposed patients with malignant-lymphoma or sarcoma. (1995) (1)
Soft tissue and visceral sarcomas (1)
External validation of an AI-driven breast cancer risk prediction model in a racially diverse cohort of women undergoing mammographic screening (2022) (1)
Trofosfamide and Etoposide-A Well Tolerated Palliative Treatment for Adults with Advanced Soft Tissue Sarcoma: A Single Center Experience (2019) (1)
Rare germline copy number variants (CNVs) and breast cancer risk (2022) (1)
Comparison of five methods for deformable, multi-modal image registration in prostate and pelvic area (2015) (1)
SELNET clinical practice guidelines for soft tissue sarcoma and GIST. (2021) (1)
Abstract OT3-06-01: KARISMA, The karma intervention study. - A tamoxifen dose determination trial (2017) (1)
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk (2019) (1)
HIV INFECTION AND DIOXIN EXPOSURE: RISK FACTORS FOR KAPOSI SARCOMA AND MALIGNANT LYMPHOMA? (1988) (1)
Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients (2021) (1)
DOSE‐DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH‐RISK DLBCL: A COMPARISON OF NORDIC CRY‐04 AND CHIC STUDIES (2017) (1)
Topical Endoxifen for Mammographic Density Reduction—A Randomized Controlled Trial (2022) (1)
Abstract: 1463 EPROTIROME: A PHYSIOLOGICAL APPROACH TO LIPID CONTROL UTILIZING A LIVER SELECTIVE THYROID HORMONE RECEPTOR AGONIST (2009) (1)
"Increased concentrations of polychlorinated biphenyls, hexachlorobenzenes, and chlordanes": Response from Hardell and Eriksson (2004) (1)
18FDG PET/CT after intensified chemo-immunotherapy in diffuse large B-cell lymphoma (DLBCL), aged 18-65 with aaIPI 2-3 positive or indeterminate lesions are often false-positive: A Nordic phase II substudy. (2011) (1)
Mutations in the LDR-receptor gene in Swedish patients with familial hypercholesterolemia (2000) (1)
SELNET Clinical practice guidelines for bone sarcoma. (2022) (1)
[Increased incidence of brain tumors. A study of Swedish children and adolescents aged 0-19]. (1997) (1)
1112 Associations of breast cancer risk prediction tools with tumor characteristics and metastasis: Analysis of polygenic risk score, mammographic density and Tyrer-Cuzick predicted 10-year breast cancer risk (2015) (1)
Adjuvant imatinib for GIST: duration likely matters. (2021) (1)
Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden. (2022) (1)
Failure rate of standard rescue with leucovorin for high-dose methotrexate (HDMTX) in osteosarcoma. (2017) (1)
Hepatic transcriptional effects of simvastatin and the possible impact on COVID-19 (2021) (1)
Pesticide exposure as risk factor for non-Hodgkin lymphoma histopathological subgroup analysis (2018) (1)
W14.368 Significant reduction of plasma LDL-C in an ARH patient by adding ezetimibe (2004) (1)
Epidemiological studies on multiple myeloma (1992) (1)
Fibrinogen‐like protein 2 in gastrointestinal stromal tumour (2022) (1)
Studies on human macrophage lipoprotein uptake: relation to atherosclerosis. (2009) (1)
Genetic depletion of the Soat2 gene diminishes diet-induced hepatic steatosis and improves glucose tolerance in mice (2018) (0)
[The apoB/apoA-I ratio is better myocardial infarction marker than lipids]. (2006) (0)
SLUG transcription factor promotes cell proliferation and predicts outcome of patients with gastrointestinal stromal tumor (2016) (0)
Abstract 15393: Cholesterol Esterifying Enzyme Acat2 - A Target for Cardiometabolic Diseases (2015) (0)
1493PThe sarcoma policy checklist: Focusing policy efforts on sarcoma (2017) (0)
Trombocytos - ett vanligt fynd med klinisk relevans (1984) (0)
2.O.09 A EUROPEAN TREATMENT PROTOCOL FOR BONE SARCOMA IN PATIENTS OLDER THAN 40 YEARS (2010) (0)
PO1-10 REDUCTION OF ACAT2 IS AN IMPORTANT EFFECT OF CHOLESTEROL SYNTHESIS INHIBITION IN HUMAN LIVERS (2007) (0)
Effects of nicotinic acid on lipoprotein metabolism and biliary lipids (1989) (0)
Simvastatin and ezetimibe reduce plasma lipoprotein binding to human arterial proteoglycans in gallstone diseased patients (2018) (0)
2.P.344 Platelet function in hypercholesterolemia - importance of combine hyperlipidemia (1997) (0)
W13.334 Growth hormone induces LDL clearance but not bile acid synthesis in humans (2004) (0)
Superior outcome in transformed follicular lymphoma compared to de novo aggressive B-cell lymphoma treated with high-dose therapy and autologous stem-cell support (2009) (0)
Age-adjusted combined immunochemotherapy without radiotherapy in newly diagnosed PCNSL : A phase II trial of the Nordic Lymphoma Group (2011) (0)
Plasma Affinity Proteomic Immunoprofiling As a Novel Prognostic Tool in High Risk Diffuse Large B-Cell Lymphoma Patients: A Nordic Lymphoma Group Study (2014) (0)
P.6.014 Cholecystokinin peptides in cerebrospinal fluid: Findings in healthy male volunteers (1996) (0)
[Computer utilization and diagnosis classification in a medical clinic]. (1985) (0)
P229 EFFECTS OF HIGH DOSE STATIN ON THE HUMAN HEPATIC EXPRESSION OF GENES INVOLVED IN CARBOHYDRATE AND TRIGLYCERIDE METABOLISM (2010) (0)
gastrointestinal stromal Tumor: A Method for Optimizing the Timing of CT Scans in the Follow-up of Cancer Patients 1 (2014) (0)
Lymphoma Group rescue: a nonrandomized phase 2 multicenter study by the Nordic purged stem cell - intensive front-line immunochemotherapy with in vivo Long-term progression-free survival of mantle cell lymphoma after (2013) (0)
[Sweden introduces a new specific ICD-10 code for the disease familial hypercholesterolemia]. (2019) (0)
CSF Collection Time at Lumbar Puncture Is Influenced by Plasma Cholesterol and Triglycerides (2001) (0)
123 Neutrophil dysplasia is not a feature of the abnormal chromosomal clones in myelodysplastic syndromes (1997) (0)
Abstract 10013: PRDs Are Multifunctional Oral Inhibitors of PCSK9 and ACAT2 (2021) (0)
150 TG INTERACTING FACTOR ACTS AS A TRANSCRIPTIONAL REPRESSOR OF ACAT2 IN HUMAN (2011) (0)
175 THE INHIBITION OF HEPATIC ACYL COENZYME A:CHOLESTEROL ACYLTRANSFERASE (ACAT) 2 POSITIVELY AFFECTS HDL METABOLISM AND FUNCTIONALITY IN MICE (2011) (0)
Genetics Home Reference Your Guide to Understanding Genetic Conditions Multiple familial trichoepithelioma (2013) (0)
Statin-induced myopathy in a usual care setting—a prospective observational study of gender differences (2016) (0)
Identifying molecular defects in Swedish patients with FH: No influence of polygenic LDL cholesterol SNP-score (2022) (0)
Founder effects facilitate genotyping approach to molecular diagnosis in familial hypercholesterolaemia in Sweden (2021) (0)
Quality of life in genetic disease : The example of familial hypercholesterolaemia (2000) (0)
WORKSHOP 2.2: ADIPOSE TISSUE - LIVER AXIS. SOAT2 DEPLETION IMPROVES INSULIN SENSITIVITY AND HEPATIC STEATOSIS (2016) (0)
Lymphoma biology 373 B-CELL LYMPHOMA CELLS OVEREXPRESSING BMI-1 ARE CORRELATED WITH DRUG RESISTANCE THROUGH ENHANCED EXPRESSION OF SURVIVIN AND ARE MORE EFFECTIVELY ELIMINATED BY T CELLS WITH CHIMERIC RECEPTOR AGAINST CD 38 THAN CD 19 (2011) (0)
SP1-6 No effect of hormonal exposures on uveal melanoma (2011) (0)
P01.036 Treatment of Glioblastoma - improvements over two decades at a single centre (2018) (0)
Corrigendum to "SELNET clinical practice guidelines for bone sarcoma" Critical reviews in oncology/hematology, vol. 174 (2022), 1-10. (2022) (0)
Genetic variation in the immunosuppression pathway genes and breast cancer: a pooled analysis of 42,510 cases and 40,577 controls from the Breast (2015) (0)
75P Use of low-dose tamoxifen to improve mammographic screening sensitivity in premenopausal women (2021) (0)
Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening (2018) (0)
Genetic characterization of familial hypercholesterolemia in Sweden (2005) (0)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
Abstract 2256: Validation of an integrated breast cancer risk model with mammographic density in three prospective cohort studies (2022) (0)
Abstract 1740: Lifestyle determinants of mammographic density in Asian and Caucasian populations: A comparative analysis (2016) (0)
The impact of coding germline variants on contralateral breast cancer risk and survival (2023) (0)
Brain Pattern Recognition : An evaluation of how the choice of training data affect classification accuracy forinexperienced BCI-users (2014) (0)
Employment in pulp mills as a possible risk factor for soft tissue sarcoma: a case report. (1991) (0)
Postmenopausal overweight and breast cancer risk; results from the KARMA cohort (2022) (0)
Hormonal determinants of mammographic density and density change (2020) (0)
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. (2023) (0)
Abstract P4-06-15: Targeted sequencing ofBRCA1/2across a large unselected breast cancer cohort in Sweden (2018) (0)
Abstract PS8-01: Identification of women at high risk of breast cancer and in need of supplemental screening - A cohort study (2021) (0)
OP-JNCI200057 329..337 (2021) (0)
Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) (0)
Interval breast cancer is associated with interferon immune response (2022) (0)
A Randomized Controlled Trial of Soy Isoflavone Intake on Mammographic Density among Malaysian Women (2023) (0)
Associations between childhood body size and seventeen adverse outcomes: analysis of 65,057 European women (2017) (0)
External Validation of a Mammography-Derived AI-Based Risk Model in a U.S. Breast Cancer Screening Cohort of White and Black Women (2022) (0)
Abstract 962: Validation of breast cancer risk model incorporating classical risk factors and polygenic risk scores in 14 prospective cohort studies in 6 countries (2019) (0)
Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (0)
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival (2023) (0)
Body size in early life and risk of breast cancer (2017) (0)
Lifetime exposure to welding fume and risk of some rare cancers. (2022) (0)
Common germline polymorphisms associated with breast cancer-specific survival (2015) (0)
Abstract PD11-07: Use of low-dose tamoxifen to increase screening sensitivity in mammography of premenopausal women (2021) (0)
a novel candidate breast cancer susceptibility locus on (2017) (0)
Genome-wide association study of germline variants and breast cancer-speci ﬁ c mortality (2019) (0)
Author reply (1999) (0)
Reply to T. Suemasu et al. (2021) (0)
Abstract PS8-41: Low dose tamoxifen for breast cancer prevention and mammographic density reduction - a randomized controlled trial (2021) (0)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
Body mass index and breast cancer survival (2017) (0)
Title Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (0)
Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer. (2023) (0)
Familial occurrence of hematolo . gic malignancies and other diseases in muluple myeloma : a case-control study (0)
Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density (2018) (0)
Affinity proteomic profiling of plasma for proteins associated to mammographic breast density (2017) (0)
Abstract P2-06-06: A clinical model for assessment of the individual breast cancer risk (2017) (0)
A clinical model for identifying the short-term risk of breast cancer (2017) (0)
Identification and characterisation of novel associations in the CASP 8 / ALS 2 CR 12 region 1 on chromosome 2 with breast cancer risk 2 3 (2014) (0)
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women (2021) (0)
Comparison of self-reported and register-based hospital medical data on comorbidities in women (2019) (0)
Author response: Sense of coherence and risk of breast cancer (2020) (0)
Background risk of breast cancer and the association between physical activity and mammographic density (2015) (0)
Fine-mapping identifies two additional susceptibility 9q31.2. (2015) (0)
OP-ANNO180096 51..67 (2018) (0)
Abstract P2-11-20: A risk tool for digital breast tomosynthesis to predict breast cancer and guide clinical follow-up (2022) (0)
Abstract PD14-02: PD14-02 Ten-year follow-up of an image-based AI risk model for breast cancer (2023) (0)
Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study (2019) (0)
Exposure to phenoxyacetic acids and glyphosate as risk factors for non-Hodgkin lymphoma- pooled analysis of three Swedish case-control studies including the sub-type hairy cell leukemia. (2023) (0)
Inherited factors contribute to an inverse association between preeclampsia and breast cancer (2018) (0)
[Phenoxyacetic acid, chlorphenols and cancer]. (1981) (0)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
Abstract P3-09-03: Not presented (2018) (0)
SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour (2017) (0)
Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years (2020) (0)
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
Pesticide exposure in farming and forestry and the risk of uveal melanoma (2011) (0)
[Thrombocytosis--an usual finding with clinical relevance]. (1984) (0)
Time to Mammographic Density Decrease After Exposure to Tamoxifen (2022) (0)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
Rare copy number variants (CNVs) and breast cancer risk (2021) (0)
Identification of two novel mammographic density loci at 6Q25.1 (2015) (0)
COMBINING SEVERAL MOLECULAR ABNORMALITIES IN IDENTIFICATION OF HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA IMPROVES RISK-STRATIFICATION (2014) (0)
Factors Associated With False-Positive Recalls in Mammography Screening. (2023) (0)
Physical activity and mammographic density in an Asian multi-ethnic cohort (2018) (0)
Why are humans LDL-animals and mice are not? Hepatic APOB mRNA editing and plasma PLTP activity are the cause, not CETP (2018) (0)
Mitotic Count and Estimation of the Risk of GIST Recurrence in Patients Treated with Preoperative Imatinib (2019) (0)
PO4-104 HNF4 ALPHA IS ESSENTIAL FOR ACAT2 REGULATION IN HUMAN: LESSON FROM THE MODY PATIENTS (2007) (0)
P-10-18 CCK-4 in cerebrospinal fluid: A pilot study in healthy male volunteers (1996) (0)
Working to improve the management of sarcoma patients across Europe: a policy checklist (2018) (0)
Gemfibrozil enhances platelet activity in vivo in patients with combined hyperlipoproteinemia: a double-blind, placebo-controlled study (1994) (0)
High plasma lipoprotein(A) levels are associated with increased prevalence of cardiovascular disease and poorer metabolic control in patients with type 1 diabetes mellitus (2020) (0)
Remnant cholesterol reduction by ezetimibe and simvastatin does not affect biliary lipid concentration in gallstone patients (2016) (0)
The inhibition of hepatic ACAT2 positively affects HDL metabolism and functionality in mice (2011) (0)
Molecular dynamics studies of the glycocalyx : carbohydrates in physiological water, and their interactions with FimH (2009) (0)
The introduction of liquid chromatography for the determination of carbamate and organophosphate pesticides at Can Tho Agriculture University (1999) (0)
The use of genotyping as a first step in molecular diagnosis of familial hypercholesterolemia. (2017) (0)
Quality of life in familial hypercholesterolaemia families (2001) (0)
Abstract: 592 BLOOD LIPIDS IN 75048 TYPE 2 DIABETIC PATIENTS: A POPULATION-BASED SURVEY SHOWING CLEAR GENDER DIFFERENCES AND A NEW PICTURE OF DIABETIC DYSLIPIDEMIA (2009) (0)
Corrigendum to "SELNET clinical practice guidelines for soft tissue sarcoma and GIST" [Cancer Treat. Rev. 102 (2021) 102312]. (2023) (0)
Lipoprotein (A) Plasma Levels And Association To Cardiovascular Disease In A Stockholm County Cohort – A Retrospective Observational Cohort Registry Study (2019) (0)
[Analysis of apolipoproteins in clinical diagnosis. Standardization increases the diagnostic value]. (1994) (0)
Use of exon-based transcriptome profiling to identify novel signaling pathways and survival-associated genes in diffuse large B-cell lymphoma. (2012) (0)
1520PDevelopment of a new promising rescue agent for high dose methotrexate (HDMTX) treatment in osteosarcoma: A safety and dose finding study (2017) (0)
30 LIPID-LOWERING EFFECTS OF THE THYROID HORMONE ANALOGUE EPROTIROME REQUIRES FUNCTIONAL LDL RECEPTORS: STUDIES IN A HOMOZYGOUS FH PATIENT (2011) (0)
Case-control studies: soft-tissue sarcomas and malignant lymphomas and exposure to phenoxy acids or chlorophenols (1981) (0)
Abstract: 577 COLESEVELAM ADDED TO STABLE COMBINATION OF STATIN AND EZETIMIBE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA; THE TRIPLE TRIAL (2009) (0)
3P-0783 New molecular effects of cholesterol synthesis inhibition on hepatic cholesterol metabolism in humans (2003) (0)
Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes. (1998) (0)
KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial. (2023) (0)
157 Non-clonal response to erythropoietin in myelodysplastic syndromes (1997) (0)
CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18- 64 Years (2008) (0)
Apolipoproteinanalyser i klinisk diagnostik. Standardiseringar ökar det diagnostiska vrdet. (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mikael Eriksson?

Mikael Eriksson is affiliated with the following schools:

Karolinska Institute
University of Cambridge
Aarhus University
Uppsala University
Umeå University
Lund University

Mikael Eriksson's Academic­Influence.com Rankings

Why Is Mikael Eriksson Influential?

Mikael Eriksson's Published Works

Published Works

What Schools Are Affiliated With Mikael Eriksson?

Mikael Eriksson's AcademicInfluence.com Rankings